{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:16:18Z","timestamp":1792653378954,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cmet.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T10:55:30Z","timestamp":1564052130000},"page":"689-705.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion"],"prefix":"10.1016","volume":"30","author":[{"given":"M. Kathryn","family":"Brewer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Uittenbogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant L.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyann M.","family":"Segvich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"DePaoli-Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe R.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay E.A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon C.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine M.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley L.","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy R.","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin D.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2019.07.002_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","article-title":"The role of brain barriers in fluid movement in the CNS: is there a \u2018glymphatic\u2019 system?","volume":"135","author":"Abbott","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cmet.2019.07.002_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.cmet.2019.07.002_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2005.03.010","article-title":"Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease","volume":"85","author":"An","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cmet.2019.07.002_bib4","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/glia.23463","article-title":"Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease","volume":"66","author":"Aug\u00e9","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.cmet.2019.07.002_bib5","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1158\/0008-5472.CAN-09-0547","article-title":"Bispecific T-cell engaging antibodies for cancer therapy","volume":"69","author":"Baeuerle","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cmet.2019.07.002_bib6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/jxb\/erq411","article-title":"The evolution of glycogen and starch metabolism in eukaryotes gives molecular clues to understand the establishment of plastid endosymbiosis","volume":"62","author":"Ball","year":"2011","journal-title":"J.\u00a0Exp. Bot."},{"key":"10.1016\/j.cmet.2019.07.002_bib7","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/pr1002593","article-title":"Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease","volume":"9","author":"Barr","year":"2010","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.cmet.2019.07.002_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody-drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cmet.2019.07.002_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00410522","article-title":"The retina in Lafora disease: light and electron microscopy","volume":"212","author":"Berard-Badier","year":"1980","journal-title":"Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"10.1016\/j.cmet.2019.07.002_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/diseases4040040","article-title":"Biomarkers in lysosomal storage diseases","volume":"4","author":"Bobillo Lobato","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.cmet.2019.07.002_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yebeh.2017.12.015","article-title":"The 3rd International Lafora Epilepsy Workshop: evidence for a cure","volume":"81","author":"Brewer","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.cmet.2019.07.002_bib12","series-title":"Advances in Neurobiology: Brain Glycogen Metabolism","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-27480-1_2","article-title":"Brain glycogen structure and its associated proteins: past, present and future","author":"Brewer","year":"2019"},{"key":"10.1016\/j.cmet.2019.07.002_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yebeh.2018.11.014","article-title":"The 4th International Lafora Epilepsy Workshop: shifting paradigms, paths to treatment, and hope for patients","volume":"90","author":"Brewer","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.cmet.2019.07.002_bib14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/glia.20557","article-title":"Astrocyte glycogen and brain energy metabolism","volume":"55","author":"Brown","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.cmet.2019.07.002_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.05.009","article-title":"Intrathecal delivery of protein therapeutics to the brain: a critical reassessment","volume":"144","author":"Calias","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cmet.2019.07.002_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the \u2018high-hanging fruit\u2019","volume":"17","author":"Carter","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cmet.2019.07.002_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0165-0173(99)00003-X","article-title":"Corpora-amylacea and the family of polyglucosan diseases","volume":"29","author":"Cavanagh","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.cmet.2019.07.002_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1586\/14760584.3.6.717","article-title":"Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer\u2019s disease","volume":"3","author":"Chauhan","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.cmet.2019.07.002_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","article-title":"Intracerebroventricular delivery as a safe, long-term route of drug administration","volume":"67","author":"Cohen-Pfeffer","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib20","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1074\/jbc.273.9.5288","article-title":"Cloning of the human\u00a0equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line","volume":"273","author":"Crawford","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","article-title":"Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy","volume":"21","author":"Criado","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cmet.2019.07.002_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(89)90162-7","article-title":"Lafora-body disease with optic atrophy, macular degeneration and cardiac failure","volume":"93","author":"de Graaf","year":"1989","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib24","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","article-title":"Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin","volume":"285","author":"DePaoli-Roach","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/hmg\/ddr598","article-title":"Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity","volume":"21","author":"DePaoli-Roach","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1074\/jbc.M114.607796","article-title":"Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease","volume":"290","author":"DePaoli-Roach","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/emmm.201200241","article-title":"Deleterious effects of neuronal accumulation of glycogen in flies and mice","volume":"4","author":"Duran","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cmet.2019.07.002_bib28","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease","volume":"23","author":"Duran","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1963.tb05215.x","article-title":"Progressive myoclonus epilepsy as an inborn error of metabolism comparable to storage disease","volume":"4","author":"Edgar","year":"1963","journal-title":"Epilepsia"},{"key":"10.1016\/j.cmet.2019.07.002_bib30","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s00018-016-2249-3","article-title":"Unique carbohydrate binding platforms employed by the glucan phosphatases","volume":"73","author":"Emanuelle","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471142727.mb3004s114","article-title":"Metabolomics by gas chromatography-mass spectrometry:\u00a0combined targeted and untargeted profiling","volume":"114","author":"Fiehn","year":"2016","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.cmet.2019.07.002_bib32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/81137","article-title":"Metabolite profiling for plant functional genomics","volume":"18","author":"Fiehn","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cmet.2019.07.002_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","article-title":"Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice","volume":"11","author":"Ganesh","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/NEN.0b013e318253350f","article-title":"Laforin and malin deletions in mice produce similar neurologic impairments","volume":"71","author":"Garc\u00eda-Cabrero","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib35","first-page":"291","article-title":"Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole","volume":"8","author":"Garc\u00eda-Cabrero","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cmet.2019.07.002_bib36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibs.2009.08.002","article-title":"Lafora disease: insights into neurodegeneration from plant metabolism","volume":"34","author":"Gentry","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib37","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1074\/jbc.R117.803064","article-title":"Lafora disease offers a unique window into neuronal glycogen metabolism","volume":"293","author":"Gentry","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib38","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/B978-0-444-59565-2.00043-5","article-title":"Progressive myoclonus epilepsy","volume":"113","author":"Girard","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0021-9258(18)75966-8","article-title":"The determination of glycogen","volume":"100","author":"Good","year":"1933","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.cmet.2019.07.002_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1748-1716.2010.02131.x","article-title":"The regulation of muscle glycogen: the granule and its proteins","volume":"199","author":"Graham","year":"2010","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.cmet.2019.07.002_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1100\/tsw.2005.98","article-title":"Antibody mediated transduction of therapeutic proteins into living cells","volume":"5","author":"Hansen","year":"2005","journal-title":"Sci. World J."},{"key":"10.1016\/j.cmet.2019.07.002_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2006.03.025","article-title":"Antibody-mediated Hsp70 protein therapy","volume":"1088","author":"Hansen","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.cmet.2019.07.002_bib44","doi-asserted-by":"crossref","first-page":"20790","DOI":"10.1074\/jbc.C700090200","article-title":"Intranuclear protein transduction through a nucleoside salvage pathway","volume":"282","author":"Hansen","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0021-9258(18)38503-X","article-title":"Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen","volume":"199","author":"Illingworth","year":"1952","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0021-9258(18)38501-6","article-title":"Structure of glycogens and amylopectins. I. Enzymatic determination of chain length","volume":"199","author":"Illingworth","year":"1952","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib47","first-page":"1591","article-title":"Comparative study of the intracytoplasmic inclusions in Lafora disease and type IV glycogenosis by electron microscopy","volume":"37","author":"Ishihara","year":"1987","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.cmet.2019.07.002_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1472-6750-13-52","article-title":"High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells","volume":"13","author":"J\u00e4ger","year":"2013","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.cmet.2019.07.002_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00480169.1990.35622","article-title":"Lafora\u2019s disease in an epileptic Basset hound","volume":"38","author":"Jian","year":"1990","journal-title":"N.\u00a0Z. Vet. J."},{"key":"10.1016\/j.cmet.2019.07.002_bib50","first-page":"923","article-title":"The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection","volume":"9","author":"Jin","year":"2015","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.cmet.2019.07.002_bib51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cmet.2019.07.002_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2014.10.033","article-title":"Isotope labeling pattern study of central carbon metabolites using GC\/MS","volume":"974","author":"Jung","year":"2015","journal-title":"J.\u00a0Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib53","doi-asserted-by":"crossref","first-page":"e0181372","DOI":"10.1371\/journal.pone.0181372","article-title":"Physical structure and absorption properties of tailor-made porous starch granules produced by selected amylolytic enzymes","volume":"12","author":"Jung","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmet.2019.07.002_bib54","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1021\/ac9019522","article-title":"FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography\/mass spectrometry","volume":"81","author":"Kind","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cmet.2019.07.002_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0003-2697(62)90014-3","article-title":"A method for the colorimetric estimation of glycogen with iodine","volume":"4","author":"Krisman","year":"1962","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cmet.2019.07.002_bib57","first-page":"103","article-title":"Evaluation of a new alpha-amylase assay using 4.6-ethylidene-(G7)-1-4-nitrophenyl-(G1)-alpha-D-maltoheptaoside as substrate","volume":"27","author":"Kruse-Jarres","year":"1989","journal-title":"J.\u00a0Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.cmet.2019.07.002_bib58","first-page":"46","article-title":"Heat-moisture treatment of starches. I. Physicochemical properties","volume":"58","author":"Kulp","year":"1981","journal-title":"Cereal Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib59","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1021\/acs.bioconjchem.8b00548","article-title":"Passive immunotherapies for central nervous system disorders: current delivery challenges and new approaches","volume":"29","author":"Kumar","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF01989438","article-title":"Uber des Vorkommen amyloider KJrperchen im innern der Ganglienzellen","volume":"205","author":"Lafora","year":"1911","journal-title":"Virchows Arch. f. Path. Anat."},{"key":"10.1016\/j.cmet.2019.07.002_bib61","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy","volume":"22","author":"Lawlor","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib62","doi-asserted-by":"crossref","first-page":"45216","DOI":"10.1038\/srep45216","article-title":"Evaluation and use of disaccharides as energy source in protein-free mammalian cell cultures","volume":"7","author":"Leong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2019.07.002_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(93)80234-L","article-title":"Glycogen contains phosphodiester groups that can be introduced by UDPglucose: glycogen glucose 1-phosphotransferase","volume":"329","author":"Lomako","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cmet.2019.07.002_bib64","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s12035-016-9884-4","article-title":"Inflammation in Lafora disease: evolution with disease progression in laforin and malin knock-out mouse models","volume":"54","author":"L\u00f3pez-Gonz\u00e1lez","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cmet.2019.07.002_bib65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.cmet.2019.07.002_bib66","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1124\/dmd.104.001123","article-title":"Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice","volume":"32","author":"Lu","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cmet.2019.07.002_bib67","series-title":"Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology","author":"Luna","year":"1968"},{"key":"10.1016\/j.cmet.2019.07.002_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.expneurol.2012.04.008","article-title":"Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient\u00a0mice","volume":"236","author":"Machado-Salas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib69","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.chom.2012.09.013","article-title":"Mitochondrial metabolism of glucose and glutamine is required for intracellular growth of Toxoplasma gondii","volume":"12","author":"MacRae","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cmet.2019.07.002_bib70","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1053\/j.gastro.2014.01.017","article-title":"Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans","volume":"146","author":"Manna","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2019.07.002_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10545-011-9360-2","article-title":"Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases","volume":"35","author":"Manwaring","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"W1","key":"10.1016\/j.cmet.2019.07.002_bib72","doi-asserted-by":"crossref","first-page":"W566-70","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cmet.2019.07.002_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0887-8994(00)00276-9","article-title":"Lafora\u2019s disease: towards a clinical, pathologic, and molecular synthesis","volume":"25","author":"Minassian","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.169.3940.68","article-title":"Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells","volume":"169","author":"Moolten","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.cmet.2019.07.002_bib75","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diabetes.49.12.1967","article-title":"Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1","volume":"49","author":"Newgard","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2019.07.002_bib76","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/19.6.382","article-title":"Studies in myoclonus epilepsy. 3. The effects of amylolytic enzymes on the ultrastructure of Lafora bodies","volume":"19","author":"Nikaido","year":"1971","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.cmet.2019.07.002_bib77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cmet.2013.04.006","article-title":"Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease","volume":"17","author":"Nitschke","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2019.07.002_bib78","doi-asserted-by":"crossref","first-page":"906","DOI":"10.15252\/emmm.201707608","article-title":"Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease","volume":"9","author":"Nitschke","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cmet.2019.07.002_bib79","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.23020","article-title":"Glycogen distribution in the microwave-fixed mouse brain reveals heterogeneous astrocytic patterns","volume":"64","author":"Oe","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.cmet.2019.07.002_bib80","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/088307389901401111","article-title":"A case of Lafora\u2019s disease associated with cardiac arrhythmia","volume":"14","author":"Oksel","year":"1999","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib81","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen storage diseases: new perspectives","volume":"13","author":"Ozen","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cmet.2019.07.002_bib82","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1128\/MCB.24.16.7179-7187.2004","article-title":"Abnormal cardiac development in the absence of heart glycogen","volume":"24","author":"Pederson","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cmet.2019.07.002_bib83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.23899","article-title":"Inhibiting glycogen synthesis prevents Lafora disease in a mouse model","volume":"74","author":"Pederson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib84","first-page":"170","article-title":"Mouse models of human disease: an evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol. Med. Public Health"},{"key":"10.1016\/j.cmet.2019.07.002_bib85","first-page":"362","article-title":"Meine Methode der quantitativen Analyse des Glykogenes und die Arteigenth\u00fcmlichkeit der Substanzen des Thierleibes","volume":"129","author":"Pfl\u00fcger","year":"1909","journal-title":"Archiv f\u00fcr die gesamte Physiologie des Menschen und der Tiere"},{"key":"10.1016\/j.cmet.2019.07.002_bib86","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1113\/JP275105","article-title":"Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery","volume":"596","author":"Pizzo","year":"2018","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.cmet.2019.07.002_bib87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","article-title":"The glymphatic system in central nervous system health and disease: past, present, and future","volume":"13","author":"Plog","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cmet.2019.07.002_bib88","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1126\/science.275.5305.1475","article-title":"PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism","volume":"275","author":"Printen","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cmet.2019.07.002_bib89","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","article-title":"Surprises of genetic engineering: a possible model of polyglucosan body disease","volume":"56","author":"Raben","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cmet.2019.07.002_bib90","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2174\/1389450117666151209120139","article-title":"Delivery of therapeutic proteins: challenges and strategies","volume":"17","author":"Rehman","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.cmet.2019.07.002_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1566524024605761","article-title":"Glycogen and its metabolism","volume":"2","author":"Roach","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.cmet.2019.07.002_bib92","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0003-9861(67)90118-X","article-title":"Multiple attach hypothesis of alpha-amylase action: action of porcine pancreatic, human salivary, and Aspergillus oryzae alpha-amylases","volume":"122","author":"Robyt","year":"1967","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cmet.2019.07.002_bib93","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddy044","article-title":"Astrocytes: new players in progressive myoclonus epilepsy of Lafora type","volume":"27","author":"Rubio-Villena","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib94","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijbiomac.2009.08.006","article-title":"Comparative structural analyses of purified glycogen particles from rat liver, human skeletal muscle and commercial preparations","volume":"45","author":"Ryu","year":"2009","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cmet.2019.07.002_bib95","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.20.2.160","article-title":"Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea","volume":"20","author":"Sakai","year":"1970","journal-title":"Neurology"},{"key":"10.1016\/j.cmet.2019.07.002_bib96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physiolgenomics.00194.2006","article-title":"A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human","volume":"29","author":"Salek","year":"2007","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.cmet.2019.07.002_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/epi.13656","article-title":"Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease","volume":"58","author":"S\u00e1nchez-Elexpuru","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.cmet.2019.07.002_bib98","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.aaa9607","article-title":"Neuroscience. Metabolic control of epilepsy","volume":"347","author":"Scharfman","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cmet.2019.07.002_bib99","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","article-title":"Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects","volume":"4","author":"Shahwan","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib100","series-title":"Theory and Practice of Histotechnology","author":"Sheehan","year":"1980"},{"key":"10.1016\/j.cmet.2019.07.002_bib101","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2337\/diabetes.49.7.1096","article-title":"Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites","volume":"49","author":"Skurat","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2019.07.002_bib102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","article-title":"Clinical applications of metabolomics in oncology: a review","volume":"15","author":"Spratlin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cmet.2019.07.002_bib103","first-page":"107","article-title":"Starch granule porosity and its changes by means of amylolysis","volume":"21","author":"Sujka","year":"2007","journal-title":"Int. Agrophys."},{"key":"10.1016\/j.cmet.2019.07.002_bib104","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/bm401714v","article-title":"Changes in glycogen structure over feeding cycle sheds new light on blood-glucose control","volume":"15","author":"Sullivan","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cmet.2019.07.002_bib105","doi-asserted-by":"crossref","first-page":"E1743","DOI":"10.3390\/ijms18081743","article-title":"Pathogenesis of Lafora disease: transition of soluble glycogen to insoluble polyglucosan","volume":"18","author":"Sullivan","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib106","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0021-9258(19)52772-7","article-title":"Studies on the structure of polysaccharides; relation of the iodine color to the structure","volume":"172","author":"Swanson","year":"1948","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib107","doi-asserted-by":"crossref","first-page":"33816","DOI":"10.1074\/jbc.M807428200","article-title":"Abnormal metabolism of glycogen phosphate as a cause for Lafora disease","volume":"283","author":"Tagliabracci","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib108","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmet.2011.01.017","article-title":"Phosphate incorporation during glycogen synthesis and Lafora disease","volume":"13","author":"Tagliabracci","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2019.07.002_bib109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcs.2003.12.001","article-title":"Starch\u2014composition, fine structure and architecture","volume":"39","author":"Tester","year":"2004","journal-title":"J.\u00a0Cereal Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib110","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cmet.2019.07.002_bib111","doi-asserted-by":"crossref","first-page":"25650","DOI":"10.1074\/jbc.M111.331611","article-title":"Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient\u00a0Lafora disease","volume":"287","author":"Tiberia","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib112","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of\u00a0metabolomics to Alzheimer\u2019s disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cmet.2019.07.002_bib113","doi-asserted-by":"crossref","first-page":"e1002037","DOI":"10.1371\/journal.pgen.1002037","article-title":"PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease","volume":"7","author":"Turnbull","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cmet.2019.07.002_bib114","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.24104","article-title":"PTG protein depletion rescues malin-deficient Lafora disease in mouse","volume":"75","author":"Turnbull","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib115","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.cmet.2019.07.002_bib116","unstructured":"Valerion Therapeutics, LLC (2016). VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Patients With Late-Onset Pompe Disease (Clinicaltrials.gov Identifier NCT02898753)."},{"key":"10.1016\/j.cmet.2019.07.002_bib117","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/emmm.201100174","article-title":"Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease","volume":"3","author":"Valles-Ortega","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cmet.2019.07.002_bib118","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2019.07.002_bib119","series-title":"Handbook of Clinical Neurology","first-page":"382","article-title":"Lafora disease, a form of progressive myoclonus epilepsy","author":"Van Heycop Ten Ham","year":"1975"},{"key":"10.1016\/j.cmet.2019.07.002_bib120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1528-1157.1963.tb05214.x","article-title":"Progressive myoclonus epilepsy with Lafora bodies. Clinical-pathological features","volume":"4","author":"Van Heycop Ten Ham","year":"1963","journal-title":"Epilepsia"},{"key":"10.1016\/j.cmet.2019.07.002_bib121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00688087","article-title":"Progressive familial myoclonic epilepsy with Lafora bodies. Electron microscopic and histochemical study of a cerebral biopsy","volume":"7","author":"Van Hoof","year":"1967","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cmet.2019.07.002_bib122","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.jacc.2017.04.029","article-title":"Lafora disease is an inherited metabolic cardiomyopathy","volume":"69","author":"Villalba-Orero","year":"2017","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.cmet.2019.07.002_bib123","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfw072","article-title":"Safety evaluation of CNS administered biologics\u2014study design, data interpretation, and translation to the clinic","volume":"152","author":"Vuillemenot","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cmet.2019.07.002_bib124","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/jaut.1998.0212","article-title":"An autoantibody is modified for use as a delivery system to target\u00a0the cell nucleus: therapeutic implications","volume":"11","author":"Weisbart","year":"1998","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.cmet.2019.07.002_bib125","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp300495e","article-title":"Diffusion of macromolecules in the brain: implications for drug delivery","volume":"10","author":"Wolak","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cmet.2019.07.002_bib126","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1074\/jbc.M708712200","article-title":"Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG)","volume":"283","author":"Worby","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2019.07.002_bib127","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00109-017-1505-9","article-title":"Antibody-mediated enzyme replacement therapy targeting\u00a0both lysosomal and cytoplasmic glycogen in Pompe disease","volume":"95","author":"Yi","year":"2017","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.cmet.2019.07.002_bib128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archneur.1968.00480010033002","article-title":"Studies in myoclonus epilepsy\u00a0(Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases","volume":"19","author":"Yokoi","year":"1968","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib129","first-page":"941","article-title":"Immunological homogeneity of Lafora body, corpora amylacea, basophilic degeneration in heart, and intracytoplasmic inclusions\u00a0of liver\u00a0and heart in type IV glycogenosis","volume":"37","author":"Yokota","year":"1987","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.cmet.2019.07.002_bib130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00005072-198809000-00008","article-title":"Monoclonal antibody against polyglucosan isolated from the myocardium of a patient with Lafora disease","volume":"47","author":"Yokota","year":"1988","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cmet.2019.07.002_bib131","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1172\/JCI106592","article-title":"The metabolism of circulating maltose in man","volume":"50","author":"Young","year":"1971","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413119303754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413119303754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:32:57Z","timestamp":1761550377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413119303754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1550413119303754"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2019.07.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/679407","asserted-by":"object"}]},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}